Radiopharmaceuticals & delivery required for scheduled nuclear medicine diagnostic & therapeutic procedures.
Ended Awarded
- Contract number
- HT009026FL163
- Awardee
-
Pharmarx Hawaii LLC UEI VEBKSY2CEBF9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $12,009
Award facts
- Contract value 100% obligated
- $12,009.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Aiea, HI 96701, USA
Award details come from SAM.gov/FPDS.
About this award
Defense Health Agency issued a BPA call to Pharmarx Hawaii LLC for radiopharmaceuticals and delivery required for scheduled nuclear medicine diagnostic and therapeutic procedures, with a ceiling value of $12,009.00, effective July 20, 2026. Work is performed in Aiea, Hawaii. The call is firm fixed price with an ultimate completion date of September 30, 2026. No set-aside was used.
Quick answers
Who was awarded contract HT009026FL163?
HT009026FL163 was awarded to Pharmarx Hawaii LLC by Defense Health Agency (Department of Defense) on July 20, 2026.
How much is contract HT009026FL163 worth?
The government has obligated $12,009 on HT009026FL163.
Is contract HT009026FL163 an order under another contract?
Yes. HT009026FL163 is a BPA call under W81K0226AA007, a blanket purchase agreement.
Was contract HT009026FL163 competed?
The extent of competition for HT009026FL163 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award